Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
No one should be surprised anymore when a GLP1-R agonist (like Trulicity/Dulaglutide) or SGLT2 inhibitor gets a cardio label. These agents have proven themselves time and again for cardio risk reduction. I've lost count of how many GLP1-R agonists and SGLT2 inhibitors have received cardio labels.
